IRE ELiT and Pi Medical are entering into a commercial partnership to promote and market the Germanium-68/Gallium-68 generator, Galli Ad. Galli Ad is intended for in vitro radiolabeling of radiopharmaceutical kits and preparations developed for PET imaging. It is approved in 13 European countries and inspired by the principles of using 99mTc generators.

Met de Galli Ad kunnen m.n. neuroendocriene tumoren en prostaat gerelateerde tumoren  in een vroeg stadium gediagnosticeerd worden.

IRE ELiT has been active on the Dutch and Flemish markets with the Galli Ad since 2018. By entering into this partnership with PI Medical, Dutch customers will now find it easier to obtain technical assistance quickly. This guarantees high quality in service and expertise.

In de pdf lees je meer over IRE ELiT, de samenwerking en Gallium-68.